| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/26/2008 | CN100376236C Use of composition in preparation of nutritive product for preventing and treating keratomalacia |
| 03/26/2008 | CN100376235C Use of medicine composition in preparation of nutritive product for preventing and treating synchysis |
| 03/26/2008 | CN100376234C Use of vitamin microelement composition in preparatio of nutritive product for preventing and treating synchysis |
| 03/26/2008 | CN100376233C Use of composition in preparation of product for preventing and treating vision injury syndrome due to TV and computer display light |
| 03/26/2008 | CN100376232C Anaesthetic formulations |
| 03/26/2008 | CA2561104A1 Antimicrobial agents derived from cream |
| 03/25/2008 | USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 03/25/2008 | US7348456 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 03/25/2008 | US7348453 Complexing using an ortho carboxy acetal |
| 03/25/2008 | US7348449 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 03/25/2008 | US7348448 Substituted phenyl esters; dementia |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348437 Compound with a hydroxamate and a benzophenone group, and a functional group of rhodamine, oligonucleotides, azides, alkynes, biotin, or p-nitrophenyl; binding the active compound to the active site, forming an active compound-metalloprotease adduct; determining the potency of the inhibitor |
| 03/25/2008 | US7348436 Compounds useful for the synthesis of (+)-discodermolide and methods thereof |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348429 Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348425 Inhibitors of HCV replication |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348417 Method of purifying moxidectin through crystallization |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348363 Aquacidal compound comprising a benzoquinone; particularly effective for treating ballast water of ships or other enclosed volumes of water to control the relocation of plants, toxic bacteria, and animals contained in the water. |
| 03/25/2008 | US7348362 Bronchodilating β-agonist compositions and methods |
| 03/25/2008 | US7348361 Solution for diagnosing or treating tissue pathologies |
| 03/25/2008 | US7348360 Method and composition for delivering zinc to the nasal membrane |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348358 Use of cyclolignans |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348356 enzyme inhibitor for preventing the formation of insoluble Amyloid beta and arresting the production of Amyloid beta; prevention or treatment of such diseases in which the enzyme is involved; compound including a N-alkyl cycloalkyl group |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348354 Cyclohexylurea compounds |
| 03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
| 03/25/2008 | US7348352 Diindolylmethane for the treatment of HPV infection |
| 03/25/2008 | US7348351 for treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 03/25/2008 | US7348350 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesirable microorganisms |
| 03/25/2008 | US7348349 Oxazole derivatives |
| 03/25/2008 | US7348348 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
| 03/25/2008 | US7348347 Serotonin reuptake inhibitors; for depression and pain; 2-cyclohexyl-N-{4-[4-(2-dimethylaminoethyl)piperazin-1-carbonyl]-4,5,6,7-tetrahydrobenzthiazol-2-yl)-acetamide |
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348345 Nonnucleoside reverse transcriptase inhibitors |
| 03/25/2008 | US7348344 Polysubstituted 1,1-pyridyloxycyclopropanamine compounds |
| 03/25/2008 | US7348343 N-(N-heteroaryl)1-pyridyl- or -pyrimidyl-hydropyridine-4-carboxamides; e.g., 3'-Chloro-3,6-dihydro-2H-[1,2']bipyridinyl-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide and 1-pyrimidin-2-yl-1,2,3,6-tetrahydro-pyridine-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348340 "caused" by the stimulation of nociceptive receptors and transmitted over intact neural pathways; 2-(4-Chlorophenyl)-quinoline-4,6-diamine; acute, persistent and neuropathic pain |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348338 PPAR active compounds |
| 03/25/2008 | US7348337 heterocyclic oxo amides such as 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione, used as viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348334 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348332 (3,4-dihydro-quinazolin-2-yl)-(R)-indan-1-yl-amine; serotonin (5-HT5A) receptor antagonist/agonist; anxiolitic, antidepressant, sleep disorders and schizophrenia; amination thioquinazolin with 1-aminoindane |
| 03/25/2008 | US7348331 such as 6-(2,4-difluoro-phenoxy)-2-((S)-(+)-2-hydroxy-1-methyl-ethylamino)-8-((S)-2-hydroxy-propyl)-8H-pyrido[2,3-d]pyrimidin-7-one, used for treating p38 map kinase mediated disorders such as arthritis, Alzheimer's disease, gastrointestinal or respiratory system disorders |
| 03/25/2008 | US7348330 1-azabicyclo [2,2,2] octan-3-one derivatives |
| 03/25/2008 | US7348329 Use of 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione or N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine; dry eyes, corneal ulcer, keratitis, conjunctivitis |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | US7348325 Pyrrolotriazine kinase inhibitors |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348323 [5-(4-cyclopentyl-piperazin-1-yl)-1H-pyrrolo[2,3-c]pyridin-2-yl]-pyrrolidin-1-yl-methanone; antagonists or inverse agonists at histamine 3 receptor; obesity, antidepressant, dementia and cognitive disorders, neurological disorders |
| 03/25/2008 | US7348322 6-{2-Hydroxyimino-3-[1-(2-trifluoromethyl-phenyl)-cyclobutyl]-propylamino}-4-methyl-benzo[d][1,2]oxazin-1-one; antiallergic, asthma, artritis, graft versus host disease; side effect reduction; GR/ligand complex represses transcription of pro-inflammatory genes by directly interacting with NF-kB or AP-1 |
| 03/25/2008 | US7348321 Flumazenil for the treatment of alcohol dependency |
| 03/25/2008 | US7348320 lower toxicity and higher selectivity |
| 03/25/2008 | US7348319 amination of imidate bounded to (bio)polymer, aminoacid, or drug; reactions avoid direct contact with nitric oxide; substrate is medical device: stent, catheter, wound dressing, prosthesis, implant; restenosis, hypotensive agent, and impotency |
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348317 Aqueous compositions containing metronidazole |
| 03/25/2008 | US7348316 Use of an anti-endotoxin drug in the prevention and treatment of disease |
| 03/25/2008 | US7348315 Methods of treating heart failure with modified ATP, ADP and AMP compounds |
| 03/25/2008 | US7348314 Double-stranded ribonucleic acid |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348307 Treating Non-Hodgkins lymphoma by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 03/25/2008 | US7348305 Inhibitor of cardiac tachyarrhythmias |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348173 Fatty-acid amide hydrolase |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348032 Using plant extracts as antiproliferative agents |
| 03/25/2008 | US7348031 Method for preparing colloidal particles in the form of nanocapsules |
| 03/25/2008 | US7348027 Taste masked veterinary formulation |
| 03/25/2008 | US7348025 Small particle liposome aerosols for delivery of anticancer drugs |
| 03/25/2008 | US7348021 Immunostimulating coating for surgical devices |
| 03/25/2008 | US7348020 Invasive medical device, especially for guided tissue regeneration |
| 03/25/2008 | US7348017 such as 2-[Benzyl[(4-methoxyphenyl)sulfonyl]amino]-N-(3-thioxo-3H-1,2,4-dithiazol-5-yl)acetoamide; cosmetics; antiaging agents |
| 03/25/2008 | US7348000 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 03/25/2008 | US7347985 Antimicrobial agent comprising Magnolia Bark extract in an edible film composition in an amount sufficient to kill or deactivate oral bacteria |
| 03/25/2008 | US7347984 Mammalian agmatinase inhibitory substance |
| 03/25/2008 | US7347199 Pressurised metered dose inhalers (MDI) |
| 03/25/2008 | CA2484638C Polyene polyketides and methods of production |
| 03/25/2008 | CA2467265C Pharmaceutical composition for enhancing immunity, and extract of poria |
| 03/25/2008 | CA2432432C Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 03/25/2008 | CA2426754C Indolocarbazole anticancer agents and methods of using them |
| 03/25/2008 | CA2416867C Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2371178C Prucalopride oral solution |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2359987C 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
| 03/25/2008 | CA2333145C Drug delivery system comprising a homeobox peptide and a non-peptide, non-nucleotide drug |